Sucampo Pharma Europe's pipeline consists of products based on Sucampo's proprietary technologies derived from Dr. Ueno's discovery of a novel class of functional fatty acids as well as in-licensed products.

While the company is young, Sucampo Pharma Europe has an access to Sucampo Group's rich product pipelines for exclusive development and commercialization in Europe, Middle East and Africa. Initially, Sucampo Pharma Europe plans to start several clinical trials in ophthalmic areas.